GKOS

Glaukos
GKOS

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$5.57B
EV
$5.38B
Shares Outstanding
58.65M
Beta
0.81

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$122.46
P/E 2025E
-
P/Revenue 2025E
11.59x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Glaukos Corporation

gainify
GKOS

Glaukos Corporation

GKOS

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhanc...

Sector

Healthcare

Industry

Medical - Devices

CEO

Burns, Thomas

Employees

995

IPO Date

2015-06-25

Headquarters

One Glaukos Way, Aliso Viejo, California, 92656, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.